Public signalCompany raiseAuto-indexed · Unverified

Crosslink Therapeutics Inc. raised $4.3M

Crosslink Therapeutics Inc.· BOSTON, US· Pharmaceuticals· Filed May 15, 2025

Crosslink Therapeutics Inc. reported raising capital. Based in BOSTON, MASSACHUSETTS, US. First sale reported 2025-04-17. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.

Raised
$4.3M
Confidence90%
Raised
$4.3M
Investors
6
Incorporated
2021
Jurisdiction
DELAWARE

On the record

Location
BOSTON, US
Sector
Pharmaceuticals
Record type
Company raise
Stage
Reported raised
Amount raised
$4.3M
Target amount
$8.0M
Filing date
May 15, 2025
Issuer type
operating company

Gaps in the record

  • Valuation and deal terms are not on the public record
  • No company website on record
  • Investors are not disclosed
  • Not yet claimed or verified by the company

Filing details

Jurisdiction of incorporation
DELAWARE
Year incorporated
2021
Industry group
Pharmaceuticals
Number of investors
6
Includes non-accredited investors
No
Revenue range
Decline to Disclose
Total offering amount
$8.0M
Amendment
No

People named on this filing

Officers, directors, managers and entities listed in the public filing.

Sources & provenance

Operating company sold 4,250,000 USD under Reg D.

View original filing (SEC EDGAR Form D)

Automatically indexed from SEC EDGAR Form D · filing dated May 15, 2025. Details beyond the filing have not been verified.

Tags

USCompanyPharmaceuticals$1M – $10MCompany Raise

Are you associated with Crosslink Therapeutics Inc.?

This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.

Claim this record